DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
基本信息
- 批准号:6299825
- 负责人:
- 金额:$ 17.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-01-01 至 2000-12-31
- 项目状态:已结题
- 来源:
- 关键词:CD44 molecule animal tissue antisense nucleic acid articular cartilage cartilage metabolism chondrocytes collagen extracellular matrix fibronectins human tissue hyaluronate insulinlike growth factor integrins interleukin 1 laboratory rabbit metalloendopeptidases molecular pathology osteoarthritis protein biosynthesis protein degradation protein purification receptor binding tissue /cell culture transforming growth factors western blottings
项目摘要
Osteoarthritis (OA) is a non-inflammatory disease, even though there may
be inflammatory episodes. Thus, the typical inflammatory mediators may not
continuously induce chondrocytic chondrolysis (cartilage breakdown
mediated by the endogenous chondrocytes). During the non-inflammatory
periods, there may be other mediators of damage. We propose that
degradation components of the extracellular matrix (ECM) play active roles
in driving matrix destruction. We have documented that fibronectin (Fn)
fragments (Fn-f) enhance catabolic mediator levels and induce matrix
metalloproteinases (MMPs), resulting in cartilage degradation. Further,
our preliminary data show that collagen type II (col II) fragments (col-
f) and hyaluronan (HA) fragments (HA-f) also induce cartilage damage.
Thus, while the components of the normal ECM influence the synthesis,
assembly and degradation of macromolecules by chondrocytes, the fragmented
components of the damaged matrix alter this influence or feedback-
regulation and contribute to progression of damage. A key point is that
the parent molecules may also be elevated in various states of OA, and
would contribute to enhanced levels of ECM fragments. It is also likely
that the ECM fragments alter synthesis of matrix molecules under and
certain conditions, these may enhance reparative processes, as shown for
the Fn-f. Thus, the ECM fragments may complete the linkage between damage
and subsequent attempted repair in OA. Characterization of the effects of
fragment should suggest means of intervention to reduce metabolic damage
and thereby facilitate repair in OA. We propose (1) to investigate whether
enhancement of Fn levels by anabolic factors added to cartilage ultimately
contributes to cartilage damage through generation of Fn-f. We will also
test whether injection of Fn-f into rabbit knee joints, in an established
model, also leads to enhanced levels of Fn, which ultimately would
contribute to cartilage damage. We propose (2) to investigate the
activities of collagen type II fragments (col-f) and HA fragments (HA-f)
in mediating damage to cartilage explants in bovine and human tissue and
regulating chondrocyte metabolism, based on our preliminary observations
that these fragments do cause loss of PG and induction of MMPs in
cartilage explants. Their effects on cartilage damage when injected into
rabbit knee joints will also be assessed. We propose (3) to investigate
the role of the Fn-binding integrin, col II binding anx V and HA binding
CD44 in the regulation of cartilage homeostasis by the respective
fragments, based on preliminary data that suggest involvement of these
receptors.
骨关节炎(OA)是一种非炎症性疾病,即使
发炎发作。因此,典型的炎症介体可能不会
连续诱导软骨细胞软骨溶解(软骨破裂
由内源软骨细胞介导)。在非炎症期间
时期,可能还有其他损害的调解人。我们提出了这一点
细胞外基质(ECM)的降解成分发挥活性作用
在驾驶矩阵破坏中。我们已经记录了纤连蛋白(FN)
片段(FN-F)增强分解代谢介质水平并诱导基质
金属蛋白酶(MMP),导致软骨降解。更远,
我们的初步数据表明,II型胶原蛋白(Col II)片段(Col-
F)和透明质酸(HA)碎片(HA-F)也会诱发软骨损伤。
因此,尽管正常ECM的成分影响合成,但
由软骨细胞(碎片)组装和降解大分子
受损矩阵的组件改变了这种影响或反馈 -
调节并有助于损害的进展。一个关键是
在OA的各个状态下,母分子也可以升高,并且
将有助于提高ECM碎片水平。也可能
ECM片段改变了基质分子的合成和
某些条件,这些条件可能会增强修复过程,如图所示
FN-F。因此,ECM片段可以完成损坏之间的联系
并随后在OA中进行维修。效果的表征
碎片应提出干预手段以减少代谢损害
从而促进OA的维修。我们建议(1)调查是否
通过添加到软骨中的合成代谢因素对FN水平的提高最终
通过产生FN-F会导致软骨损伤。我们也会
测试在已建立的
模型,也导致FN级别提高,最终将
导致软骨损伤。我们建议(2)调查
胶原型II型片段(Col-F)和HA片段(HA-F)的活动
在介导牛和人组织中软骨外植体的损害中
根据我们的初步观察,调节软骨细胞代谢
这些碎片确实会导致PG的丢失和MMP的诱导
软骨外植体。注射到软骨伤害时,它们的影响
还将评估兔膝关节。我们建议(3)调查
FN结合整合素,Col II结合Anx V和HA结合的作用
CD44在各自的软骨稳态调节中
片段,基于提示这些参与的初步数据
受体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GENE HOMANDBERG其他文献
GENE HOMANDBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GENE HOMANDBERG', 18)}}的其他基金
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6434891 - 财政年份:2001
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6332453 - 财政年份:2000
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6217128 - 财政年份:1999
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6100474 - 财政年份:1999
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6295695 - 财政年份:1999
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6268361 - 财政年份:1998
- 资助金额:
$ 17.02万 - 项目类别:
相似国自然基金
研制兼具管状软骨、血管化和上皮化的仿真气管组织用于修复大动物长段气管缺损
- 批准号:82302395
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于植物甾醇颗粒和凝胶粒子构建双相乳液凝胶模拟动物脂肪组织弹塑性行为和感官特性的分子机制研究
- 批准号:32272243
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
棘皮动物可变结缔组织可塑性的遗传基础与调控机制
- 批准号:42276143
- 批准年份:2022
- 资助金额:56 万元
- 项目类别:面上项目
基于植物甾醇颗粒和凝胶粒子构建双相乳液凝胶模拟动物脂肪组织弹塑性行为和感官特性的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
预构血管化、上皮化组织工程气管修复大动物长段气管缺损及其上皮功能重建机制的研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6434891 - 财政年份:2001
- 资助金额:
$ 17.02万 - 项目类别:
Patient-oriented Research: Colon CA & Cancer Immunology
以患者为导向的研究:Colon CA
- 批准号:
7251986 - 财政年份:2001
- 资助金额:
$ 17.02万 - 项目类别:
Patient-oriented Research: Colon CA & Cancer Immunology
以患者为导向的研究:Colon CA
- 批准号:
7386702 - 财政年份:2001
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6332453 - 财政年份:2000
- 资助金额:
$ 17.02万 - 项目类别:
DEGRADATION PRODUCTS OF THE CARTILAGE MATRIX INFLUENCE
软骨基质影响的降解产物
- 批准号:
6217128 - 财政年份:1999
- 资助金额:
$ 17.02万 - 项目类别: